Role of Acetazolamide (Diamox) in Cataract Surgery
Acetazolamide should be used selectively in cataract surgery—primarily for prophylaxis against postoperative IOP spikes in high-risk patients (glaucoma, pseudoexfoliation syndrome) rather than routinely in all cases.
Primary Indication: IOP Control in High-Risk Patients
The FDA-approved indication for acetazolamide includes preoperative use in acute angle-closure glaucoma and chronic open-angle glaucoma 1. In the cataract surgery context, its role is specifically targeted:
When to Use Acetazolamide
Use prophylactically in:
- Primary open-angle glaucoma (POAG) patients undergoing phacoemulsification
- Pseudoexfoliation syndrome patients
- Patients with pre-existing glaucoma at risk for pressure spikes
Optimal timing and dosing:
- 500 mg oral acetazolamide administered 1 hour preoperatively is most effective 2, 3
- This timing significantly reduces IOP elevation from 1-24 hours postoperatively
- Preoperative administration reduces IOP spike incidence to 3.3% versus 23-27% without prophylaxis 2
When NOT to Use Acetazolamide
Avoid routine use in:
- Low-risk patients undergoing uncomplicated phacoemulsification with anterior chamber maintainer
- In these patients, acetazolamide provides only modest, clinically insignificant IOP reduction (14.0 vs 15.4 mmHg at day 1) with no difference by day 7 4
- The minimal benefit does not justify the 10% incidence of systemic side effects 4
Evidence-Based Timing Strategy
The research demonstrates clear superiority of preoperative versus postoperative administration:
- 1 hour preoperatively: Significantly lower IOP at 1,3,5,7, and 24 hours postoperatively 2, 3
- 3 hours postoperatively: Only reduces IOP at 5 hours and beyond—misses the critical early spike window 2, 3
- No administration: IOP spikes occur at 3-7 hours postoperatively in high-risk eyes 2, 3
Alternative Role: Macular Edema Prevention
Acetazolamide 250 mg/day postoperatively is as effective as topical ketorolac 0.5% in preventing macular thickness increases after cataract surgery 5. However, NSAIDs remain first-line due to better safety profile.
Critical Safety Considerations
Absolute Contraindications in Cataract Surgery Context:
- Elderly patients with chronic renal failure and diabetes: Risk of life-threatening metabolic acidosis and coma 6
- Advanced renal impairment: Drug accumulation leads to severe acidosis 6
- Sulfonamide allergy (though cross-reactivity with antimicrobial sulfonamides is limited) 7
Serious Adverse Events to Monitor:
Bilateral choroidal detachment can occur even with prophylactic dosing (500 mg IV), presenting as:
- Bullous choroidal detachment without angle closure
- Symptoms mimicking rhegmatogenous retinal detachment
- Can be asymptomatic in fellow eye 8
Common Side Effects:
- 10% experience mild, transient systemic symptoms (paresthesias, fatigue, GI upset) 4
- Metabolic acidosis (especially with renal impairment)
- Electrolyte disturbances
Practical Algorithm for Use
Step 1: Risk stratification
- High-risk: POAG, pseudoexfoliation, pre-existing glaucoma → Consider acetazolamide
- Low-risk: Uncomplicated cataract, no glaucoma → Do NOT use routinely
Step 2: Screen for contraindications
- Check renal function (especially elderly, diabetic patients)
- Verify no sulfonamide allergy
- Assess for metabolic acidosis risk factors
Step 3: If using acetazolamide
- Dose: 500 mg oral
- Timing: 1 hour preoperatively (NOT postoperatively)
- Monitor IOP at 1,3,5,7, and 24 hours postoperatively
Step 4: Coordinate with primary care
- Monitor electrolytes and renal function in at-risk patients 7
- Watch for signs of metabolic acidosis (confusion, hyperventilation, lethargy)
Key Pitfalls to Avoid
- Do not use routinely in all cataract patients—the 2022 AAO guidelines do not recommend universal prophylaxis 9
- Do not administer postoperatively—this misses the critical 1-3 hour window when IOP spikes begin 2
- Do not use in elderly diabetics with renal impairment without careful risk-benefit assessment and monitoring 6
- Do not assume it's needed with modern surgical techniques—anterior chamber maintainers reduce IOP spikes, making routine prophylaxis unnecessary in low-risk cases 4